Home NDC 50268-649 Oxcarbazepine
Product NDC 50268-649
11-digit product format 502680649
Labeler code 50268
Product ID 50268-649_ed85a3c4-5221-9051-e053-2a95a90a703b
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Oxcarbazepine
Dosage form SUSPENSION
Route ORAL
Labeler AvPAK
Application ANDA202961
Marketing category ANDA
Marketing start 2021-06-14
Marketing end 0000-00-00
Substance OXCARBAZEPINE
Active strength 300 mg/5mL
Pharmacologic classes Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 50268-649-12 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 50268-649-12 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 50268-649-12 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 50268-649-12 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 50268-649-12 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 50268-649-12 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 50268-649-12 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 50268-649-12 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 50268-649-12 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 50268-649-12 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 50268-649-12 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 50268-649-12 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A202961-001 OXCARBAZEPINE OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A202961-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A202961-001 OXCARBAZEPINE 300MG/5ML SUSPENSION / ORAL AB 2012-09-17 cb3db0bc1861…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50268-649-05 Oxcarbazepine 5 mL in 1 CUP, UNIT-DOSE SUSPENSION 5 2 50268-649-30 Oxcarbazepine 30 in 1 TRAY SUSPENSION 30 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50268-649 OXCARBAZEPINE SUSPENSION [AVPAK] 2 Legacy NDC, 2 package rows 20230419_f89a012f-3c0c-5b80-e053-6394a90ad99f.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 50268-649-05 50268064905 5 mL in 1 CUP, UNIT-DOSE 5 ml Historical 50268-649-12 50268064912 20 CUP, UNIT-DOSE in 1 BOX (50268-649-12) > 5 mL in 1 CUP, UNIT-DOSE (50268-649-11) 2021-06-14 0000-00-00 No No Current 50268-649-30 50268064930 30 in 1 TRAY Historical